Skip to main content

Day: July 16, 2020

LSI Industries Receives Samsung Smart Signage Award For “Food & Beverage Installation of the Year”

CINCINNATI, July 16, 2020 (GLOBE NEWSWIRE) — LSI Industries (NASDAQ: LYTS) said today that the company has received Samsung’s Smart Signage Award for Food & Beverage Installation of the Year.  The award recognizes LSI for developing communication solutions for quick service restaurant (QSR) customers using innovative digital signage technology. “We are honored to receive this outstanding recognition from Samsung, and we thank them for being a trusted supplier and valued business partner,” said Jim Clark, President and CEO of LSI Industries.  “The award reflects our commitment to working closely with customers in order to understand their needs and deliver high-performance, innovative solutions.” As previously announced by LSI in April of 2020, a large QSR chain awarded the company new business valued at more than $100 million...

Continue reading

Vystar to Produce RxAir400 UV-C Light Air Purifiers with New Manufacturer

CDC reports UV-C Light Germicidal Irradiation (UVGI) as one of “most promising methods” for Coronavirus decontamination of facemasks.1RxAir400 employs powerful UVGI proven to inactivate >99.9% of viruses and pathogensReduces virus exposure risk in schools, restaurants, retail and office facilitiesWorcester, MA, July 16, 2020 (GLOBE NEWSWIRE) — Vystar Corporation (OTCQB: VYST) has restarted production of its RxAir®400 Ultraviolet (UV) light air purification systems with a new manufacturer that will enable enhanced reliability for supply chain, production and delivery. RxAir400 is a smaller, consumer/small business-sized version of the industrial size Rx3000 FDA-certified Class II medical device UV light air purifier designed for disinfection use in hospitals. Vystar anticipates receiving the first shipment of 10,000 RxAir400...

Continue reading

Interoil proposes amendments of bond terms

Oslo, 16 July 2020Interoil Exploration and Production ASA (the “Company”) has summoned a written resolution to introduce certain flexibility in the payment terms of the interests on the Senior Secured Callable Bonds with ISIN NO 001 0729908 (the “Bonds”).The proposed flexibility consists in the option of the Company to settle the payment of 50 per cent of the next three interest payments due and payable on 31 July 2020, 31 January 2021 and 31 July 2021, respectively, in kind by the issuance and delivery of new bonds with terms and conditions substantially equal to those of the outstanding bonds. The remaining 50 per cent of the interest payments due on 31 July 2020, 31 January 2021 and 31 July 2021, respectively, is to be settled in cash.Please see the attached summons for further background and a complete and detailed description of...

Continue reading

Invalda INVL signed employee stock option contracts

Invalda INVL, following the Rules for Granting Equity Incentives approved by the General Meeting of Shareholders on 1 July 2020 and pursuant to the decision of the said shareholders’ meeting on concluding option contracts with employees of Invalda INVL and of the companies, in which Invalda INVL owns 50 per cent or more of shares, signed option contracts for 232,210 ordinary registered shares of Invalda INVL AB.Invalda INVL concludes contracts on the issuance of share options to employees annually. On the basis of option contracts concluded in 2018, employees will be able to acquire up to 59,674 Invalda INVL shares in 2021, on the basis of option contracts concluded in 2019, employees will be able to acquire up to 70,397 shares in 2022, and on the basis of option contracts concluded on 1 June and 15 July this year, employees will...

Continue reading

„Invalda INVL“ pasirašė darbuotojų akcijų opcionų sutartis

Akcinė bendrovė „Invalda INVL“, vykdydama 2020 m. liepos 1 d. visuotiniame akcininkų susirinkime patvirtintų Akcijų suteikimo taisyklių nuostatas bei vadovaudamasi minėto akcininkų susirinkimo sprendimu dėl opcionų sutarčių sudarymo, su akcinės bendrovės „Invalda INVL“ ir įmonių, kurių daugiau kaip 50 proc. akcijų priklauso akcinei bendrovei „Invalda INVL“ darbuotojais sudarė opcionų sutartis dėl 232.210 paprastųjų vardinių akcinės bendrovės „Invalda INVL“ akcijų.„Invalda INVL“ sutartis dėl akcijų opcionų skyrimo darbuotojams sudaro kasmet. 2018 m. sudarytų opcionų sutarčių pagrindu darbuotojai 2021 m. galės įsigyti iki 59.674 „Invaldos INVL“ akcijų, 2019 m. sudarytų opcionų sutarčių pagrindu darbuotojai 2022 m. galės įsigyti iki 70.397 akcijų, o šių metų birželio 1 d. ir liepos 15 d. sudarytų opcionų sutarčių pagrindu darbuotojai 2023...

Continue reading

Construction Equipment Market to Hit USD 160.84 billion by 2027; Optimization of Supply Networks in the Construction Industry to Benefit the Market Growth: Fortune Business Insights™

Pune, July 16, 2020 (GLOBE NEWSWIRE) — The global construction equipment market size is projected to reach USD 160.84 billion by 2027, exhibiting a CAGR of 2.8% during the forecast period. Surging demand for construction activities will be one of the primary growth drivers for this market, finds Fortune Business Insights™ in its recent report, titled “Construction Equipment Market Size, Share and COVID-19 Impact Analysis, By Equipment Type (Earthmoving Equipment, Material Handling Equipment & Cranes, Concrete Equipment, Road Building Equipment, Civil Engineering Equipment, Crushing and Screening Equipment and Other Equipment), By Application (Residential, Commercial & Industrial) and Regional Forecast, 2020-2027”.A collaborative study by Oxford Economics and Global Construction Perspectives revealed that in terms of value...

Continue reading

MTBC Announces Commencement of Public Offering of Preferred Stock

SOMERSET, N.J., July 16, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced the commencement of an underwritten public offering of approximately 800,000 shares of its non-convertible 11% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) at a proposed price of $25.00 per share. In connection with the offering, MTBC expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the Series A Preferred Stock offered in the public offering.B. Riley FBR, Ladenburg Thalmann and National Securities Corporation are acting as bookrunning managers for the offering. The Benchmark Company, Boenning & Scattergood, Chapin Davis, Colliers Securities LLC and Wedbush...

Continue reading

Clarmin Explorations Inc. Announces Proposed Management Team and Board of Directors of the Resulting Issuer

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, July 16, 2020 (GLOBE NEWSWIRE) — Clarmin Explorations Inc. (TSX.V: CX) (the “Company” or “Clarmin”), a Tier 2 mining issuer listed on the TSX Venture Exchange (the “TSXV”), is pleased to announce the proposed management team and board of directors of the issuer (the “Resulting Issuer”) resulting from the proposed reverse takeover of the Company by Cybin Corp. (“Cybin”), a private psilocybin and nutraceutical company (the “Proposed Transaction”).The following is a brief biography of the proposed executive officers and directors of the Resulting Issuer:Paul Glavine, Director and Chief Executive OfficerPaul Glavine is the Co-founder and Chief Executive Officer of Cybin. He is a serial entrepreneur and investor...

Continue reading

Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant

Development funded under contract award from NIAID/NIH as part of the CIVICs programCurrently no approved universal influenza vaccineCDC estimates 35.5 million people were infected with influenza in U.S. during 2018-2019 seasonCollaboration will combine Dynavax’s CpG 1018 with influenza antigens designed to protect against all strains of influenzaNEW YORK and EMERYVILLE, Calif., July 16, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, and the Icahn School of Medicine at Mount Sinai (“Mount Sinai”) today announced they have entered into a collaboration to develop a universal influenza (flu) vaccine. Mount Sinai’s current work in this area is funded under a contract award from the National Institute of Allergy and Infectious...

Continue reading

Kvika banki hf.: Letter of intent for the purchase of Netgíró hf.

Kvika has signed a letter of intent for the purchase of 80% share in Netgíró. The bank Currently owns around 20% share in the company and will therefore, if the purchase goes through, become the sole owner of the company.The purchase of Netgíró is in line with the bank’s policy to use technological solutions to modernize financial services. Netgíró has focused the development of credit ratings as well as offering simple installment payments. The bank has previously successfully launched the fintech service Auður.    Kvika has had a successful collaboration with Netgíró in the past years, including financing of the company’s claims. The purchase will enable the bank to further strengthen the collaboration with the company which will lead to increased efficiency and optimization for both parties. Netgíró currently operates in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.